Targeting the MAPK pathway to increase sensitivity of ovarian carcinoma cells to platinum compounds

被引：0
|
作者：
Cossa, G. [1 ]
Lanzi, C. [1 ]
Gatti, L. [1 ]
Beretta, G. L. [1 ]
Cassinelli, G. [1 ]
Carenini, N. [1 ]
De Cecco, L. [1 ]
Canevari, S. [1 ]
Zunino, F. [1 ]
Perego, P. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori Expt Oncol & Mol Med, Milan, Italy
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72030-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [21] FYN expression is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Noda, Takuya
    Awazu, Yuichiro
    Nanno, Shigenori
    Imai, Kenji
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A207
  • [22] Platinum Sensitivity as an Independent Prognostic Factor in Patients with Brain Metastases from Ovarian Carcinoma
    Azam, Faisal
    Wong, Helen
    Hayat, Khizar
    O'Hagan, Julie
    Lord, Rosemary
    Green, John Windara
    MIDDLE EAST JOURNAL OF CANCER, 2011, 2 (3-4) : 93 - 98
  • [23] Targeting JAK/STAT pathway via extracellular vesicles overcomes platinum resistance in ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Yoshida, Kosuke
    Kitagawa, Masami
    Nagao, Yukari
    Kitai, Miho
    Sudo, Tamotsu
    Yamamoto, Yusuke
    Kajiyama, Hiroaki
    CANCER SCIENCE, 2025, 116 : 1291 - 1291
  • [24] TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma
    Matsubara, Hiroaki
    Fukuda, Takeshi
    Shimomura, Masahiro
    Tasaka, Reiko
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S9 - S9
  • [25] TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma
    Tasaka, Reiko
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Wada, Takuma
    Kawanishi, Masaru
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2018, 15 (03) : 3085 - 3090
  • [26] Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
    Caumanns, Joseph J.
    van Wijngaarden, Anne
    Kol, Arjan
    Meersma, Gert J.
    Jalving, Mathilde
    Bernards, Rene
    van der Zee, Ate G. J.
    Wisman, G. Bea A.
    de Jong, Steven
    CANCER LETTERS, 2019, 461 : 102 - 111
  • [27] Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours
    Sargent, JM
    Elgie, AW
    Williamson, CJ
    Taylor, CG
    BRITISH JOURNAL OF CANCER, 1996, 74 (11) : 1730 - 1733
  • [28] The association between estrogen receptor alpha and platinum sensitivity in ovarian cancer cells
    Matsumura, Sohei
    Ohta, Tsuyoshi
    Takahashi, Toshifumi
    Takahashi, Kazuhiro
    Nagase, Satoru
    CANCER RESEARCH, 2015, 75
  • [29] The effects of SBHA on Notch 1 expression and platinum sensitivity in ovarian cancer cells
    Rose, Stephen L.
    Kunnimalaiyaan, Muthusamy
    Drenzek, Jessica
    Seiler, Nicole
    CANCER RESEARCH, 2010, 70
  • [30] Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance
    Brown, C. A.
    McCabe, N.
    Gourley, C.
    McCavigan, A.
    Michle, C. O.
    El-Helai, A.
    Price, B.
    McGivern, N.
    Churchman, M.
    O'Brien, E. J.
    Hill, L.
    Davison, T. S.
    Williams, A.
    McCluggage, W. G.
    Keating, K. E.
    Harkin, D. P.
    Kennedy, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1005 - 1005
12345